Peter Griffin posted in diabetes • islet cells • LCT • xenotransplantation on July 17th, 2009.
UPDATE: Living Cell Technologies, a New Zealand-based biotech firm, has just announced that it is commencing trials on a potentially revolutionary diabetes treatment. The treatment will be based on xenotransplantation – the transplantation of animal cells, tissues or organs into human patients. In this case, LCT has been granted approval to transplant pig islet cells […]
Continue reading “Xenotransplantation and the LCT trials in New Zealand”